---
title: Oxcarbazepine
description: >-
  Oxcarbazepine is an anticonvulsant medication primarily prescribed for the
  treatment of focal-onset seizures (also known as partial seizures) in adults
  and children. It is sometimes used off-label for other conditions such as
  bipolar disorder, neuropathic pain, and trigeminal neuralgia.  Its phar...
is_banned: false
lastModified: '2025-09-22T17:21:53.808Z'
faqs:
  - q: >-
      What is the recommended dosage for Oxcarbazepine?**


      **A:**  Adults: Initial 300 mg twice daily, maintenance 600-2400 mg/day
      (immediate release), 1200-2400 mg/day (extended release).  Children (4-16
      years): Initial 8-10 mg/kg/day, maintenance up to 46 mg/kg/day (immediate
      release), titrated to target dose based on weight (extended release).
    a: >-
      A:**  Adults: Initial 300 mg twice daily, maintenance 600-2400 mg/day
      (immediate release), 1200-2400 mg/day (extended release).  Children (4-16
      years): Initial 8-10 mg/kg/day, maintenance up to 46 mg/kg/day (immediate
      release), titrated to target dose based on weight (extended release).
  - q: >-
      How is Oxcarbazepine metabolized?**


      **A:** Primarily to its active metabolite, MHD, largely by cytosolic
      reductase enzymes.  CYP3A4 plays a minor role.
    a: >-
      A:** Primarily to its active metabolite, MHD, largely by cytosolic
      reductase enzymes.  CYP3A4 plays a minor role.
  - q: |-
      What are the most common side effects?**

      **A:** Dizziness, drowsiness, fatigue, headache, nausea, diplopia, tremor.
    a: 'A:** Dizziness, drowsiness, fatigue, headache, nausea, diplopia, tremor.'
  - q: |-
      What are the serious side effects of Oxcarbazepine?**

      **A:** Hyponatremia, Stevens-Johnson syndrome, suicidal ideation.
    a: 'A:** Hyponatremia, Stevens-Johnson syndrome, suicidal ideation.'
  - q: >-
      What are the contraindications for using Oxcarbazepine?**


      **A:** Hypersensitivity to oxcarbazepine or carbamazepine, second or
      third-degree AV block.
    a: >-
      A:** Hypersensitivity to oxcarbazepine or carbamazepine, second or
      third-degree AV block.
  - q: >-
      Does Oxcarbazepine interact with other medications?**


      **A:** Yes, with numerous medications, especially CYP3A4 and UGT
      inducers/inhibitors, hormonal contraceptives and other antiepileptic
      drugs.
    a: >-
      A:** Yes, with numerous medications, especially CYP3A4 and UGT
      inducers/inhibitors, hormonal contraceptives and other antiepileptic
      drugs.
  - q: >-
      Can Oxcarbazepine be used during pregnancy?**


      **A:** Use with caution; it's a Pregnancy Category C drug with potential
      fetal risks.
    a: >-
      A:** Use with caution; it's a Pregnancy Category C drug with potential
      fetal risks.
  - q: |-
      How should Oxcarbazepine be discontinued?**

      **A:** Gradually, to minimize the risk of increased seizure frequency.
    a: 'A:** Gradually, to minimize the risk of increased seizure frequency.'
  - q: >-
      What monitoring parameters are important for patients taking
      Oxcarbazepine?**


      **A:** Serum sodium, liver function tests, complete blood count.
    a: 'A:** Serum sodium, liver function tests, complete blood count.'
  - q: >-
      Is there a difference between Oxtellar XR and Trileptal?**


      **A:**  Oxtellar XR is an extended-release formulation taken once daily,
      while Trileptal is an immediate-release formulation taken twice daily.
    a: >-
      A:**  Oxtellar XR is an extended-release formulation taken once daily,
      while Trileptal is an immediate-release formulation taken twice daily.
---
## **Usage**

Oxcarbazepine is an anticonvulsant medication primarily prescribed for the treatment of focal-onset seizures (also known as partial seizures) in adults and children. It is sometimes used off-label for other conditions such as bipolar disorder, neuropathic pain, and trigeminal neuralgia.  Its pharmacological classification is anticonvulsant (specifically, a voltage-sensitive sodium channel blocker).

Oxcarbazepine's mechanism of action involves blocking voltage-sensitive sodium channels in the brain. This action stabilizes neuronal membranes and reduces the repetitive firing of neurons, which helps to prevent seizures.

## **Alternate Names**

While "oxcarbazepine" is the generic name, it's marketed under various brand names such as Trileptal and Oxtellar XR.

## **How It Works**

**Pharmacodynamics:** Oxcarbazepine exerts its anticonvulsant effect primarily through the blockade of voltage-gated sodium channels in the brain.  This reduces the excitability of neurons and inhibits the spread of seizure activity.  It also modulates calcium channels and high-voltage-activated calcium channels.

**Pharmacokinetics:** Oxcarbazepine is rapidly absorbed after oral administration. It is extensively metabolized in the liver, primarily to its active metabolite, 10-monohydroxycarbazepine (MHD). MHD is responsible for most of the anticonvulsant activity.  Oxcarbazepine's elimination is primarily through renal excretion, with a small portion eliminated through the feces. Cytochrome P450 enzymes (CYP3A4 and CYP2C19) play a minor role in oxcarbazepine metabolism, and its primary metabolic pathway is through reduction by cytosolic reductase enzymes, followed by glucuronidation.

**Mode of Action:** Oxcarbazepine binds to the alpha subunit of voltage-gated sodium channels, preventing their activation and inhibiting the influx of sodium ions into neurons. This stabilizes the neuronal membrane potential and reduces the likelihood of neuronal firing and subsequent seizure propagation.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

* **Initial:** 300 mg twice daily (600 mg/day total).
* **Maintenance:**  600-2400 mg/day (immediate release), 1200-2400 mg/day (extended release), adjusted based on clinical response and tolerability.  Dosage increases should be made at weekly intervals.

#### **Children (4-16 years):**

* **Initial:** 8-10 mg/kg/day in two divided doses.
* **Maintenance:**  Dosage is titrated based on clinical response and tolerability up to a maximum of 46 mg/kg/day (immediate release) or a targeted dose based on weight (extended release), with adjustments made at weekly intervals.

#### **Special Cases:**

* **Elderly Patients:** Start with a lower dose (e.g., 300 mg/day or 450 mg/day for extended-release) and titrate slowly based on renal function and clinical response.
* **Patients with Renal Impairment:** Dose reduction is necessary.  For severe impairment (CrCl < 30 mL/min), reduce the starting dose by 50% and titrate cautiously. Immediate-release is preferred over extended-release for patients with end-stage renal disease.
* **Patients with Hepatic Dysfunction:** No dosage adjustment is needed for mild to moderate hepatic impairment.  Use with caution in severe hepatic impairment.
* **Patients with Comorbid Conditions:** Monitor for potential drug interactions, particularly with medications metabolized by CYP3A4 or UGT enzymes.

### **Clinical Use Cases**

Oxcarbazepine's primary indication is for focal-onset seizures. It is not specifically indicated for intubation, surgical procedures, mechanical ventilation, ICU use, or emergency situations such as status epilepticus or cardiac arrest.

### **Dosage Adjustments**

Dose adjustments may be necessary based on individual patient factors, including renal or hepatic impairment, co-administration of CYP3A4 or UGT inducers, and clinical response.  Genetic polymorphisms affecting drug metabolism should be considered.

## **Side Effects**

### **Common Side Effects:**

Dizziness, drowsiness, fatigue, headache, nausea, vomiting, double vision, tremor, abdominal pain, rash, hyponatremia.

### **Rare but Serious Side Effects:**

Severe hyponatremia, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), suicidal ideation, ataxia, multiorgan hypersensitivity, cardiac conduction abnormalities.

### **Long-Term Effects:**

Chronic hyponatremia, osteoporosis (with long-term use).

### **Adverse Drug Reactions (ADR):**

Severe hyponatremia, hepatic injury, blood dyscrasias, allergic reactions, cardiac arrhythmias.

## **Contraindications**

Hypersensitivity to oxcarbazepine or carbamazepine, second or third-degree atrioventricular block.

## **Drug Interactions**

Oxcarbazepine interacts with numerous medications, including other anticonvulsants (e.g., phenytoin, carbamazepine, valproic acid), hormonal contraceptives, certain antibiotics (e.g., erythromycin, ciprofloxacin), and medications metabolized by CYP3A4 or UGT enzymes. Alcohol, grapefruit juice, and smoking may also affect drug levels.

## **Pregnancy and Breastfeeding**

Pregnancy Safety Category: C.  Oxcarbazepine can cross the placenta and has been associated with an increased risk of birth defects, especially when used during the first trimester.  It is excreted in breast milk and may cause adverse effects in nursing infants.  Weigh the risks and benefits carefully before using during pregnancy or breastfeeding.

## **Drug Profile Summary**

* **Mechanism of Action:** Blocks voltage-gated sodium channels, reducing neuronal excitability.
* **Side Effects:** Dizziness, drowsiness, nausea, hyponatremia (common); Stevens-Johnson syndrome, suicidal ideation (rare but serious).
* **Contraindications:** Hypersensitivity, atrioventricular block.
* **Drug Interactions:** Numerous drug interactions, especially with CYP3A4 and UGT inducers/inhibitors.
* **Pregnancy & Breastfeeding:**  Use with caution; potential fetal risks and excretion in breast milk.
* **Dosage:**  Adults: 600-2400 mg/day; Children: 8-46 mg/kg/day. Adjust based on individual factors.
* **Monitoring Parameters:** Serum sodium levels, liver function tests, complete blood count.

## **Popular Combinations**

Oxcarbazepine is often used in combination with other anticonvulsants when monotherapy is insufficient. Common combinations include lamotrigine, levetiracetam, and valproic acid.

## **Precautions**

* Screen for hyponatremia and monitor serum sodium levels regularly.
* Monitor liver function and complete blood count, especially during the initial phase of therapy.
* Exercise caution in patients with renal or hepatic impairment.
* Advise patients about the risk of drowsiness and dizziness and caution against activities requiring alertness.
* Monitor for mood changes and suicidal thoughts.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Oxcarbazepine?**

**A:**  Adults: Initial 300 mg twice daily, maintenance 600-2400 mg/day (immediate release), 1200-2400 mg/day (extended release).  Children (4-16 years): Initial 8-10 mg/kg/day, maintenance up to 46 mg/kg/day (immediate release), titrated to target dose based on weight (extended release).

### **Q2: How is Oxcarbazepine metabolized?**

**A:** Primarily to its active metabolite, MHD, largely by cytosolic reductase enzymes.  CYP3A4 plays a minor role.

### **Q3: What are the most common side effects?**

**A:** Dizziness, drowsiness, fatigue, headache, nausea, diplopia, tremor.

### **Q4:  What are the serious side effects of Oxcarbazepine?**

**A:** Hyponatremia, Stevens-Johnson syndrome, suicidal ideation.

### **Q5: What are the contraindications for using Oxcarbazepine?**

**A:** Hypersensitivity to oxcarbazepine or carbamazepine, second or third-degree AV block.

### **Q6: Does Oxcarbazepine interact with other medications?**

**A:** Yes, with numerous medications, especially CYP3A4 and UGT inducers/inhibitors, hormonal contraceptives and other antiepileptic drugs.

### **Q7: Can Oxcarbazepine be used during pregnancy?**

**A:** Use with caution; it's a Pregnancy Category C drug with potential fetal risks.

### **Q8:  How should Oxcarbazepine be discontinued?**

**A:** Gradually, to minimize the risk of increased seizure frequency.

### **Q9: What monitoring parameters are important for patients taking Oxcarbazepine?**

**A:** Serum sodium, liver function tests, complete blood count.


### **Q10: Is there a difference between Oxtellar XR and Trileptal?**

**A:**  Oxtellar XR is an extended-release formulation taken once daily, while Trileptal is an immediate-release formulation taken twice daily.
